Results 1 to 10 of about 433,927 (377)

Platelet activating factor receptor antagonists improve the efficacy of experimental chemo- and radiotherapy [PDF]

open access: goldClinics, 2018
Platelet activating factor is a lipid mediator of inflammation, and in recent decades, it has emerged as an important factor in tumor outcomes. Platelet activating factor acts by specific binding to its receptor, which is present in both tumor cells and ...
Ildefonso Alves da Silva Junior   +3 more
doaj   +4 more sources

Platelet-Activating Factor Receptor Ligands Protect Tumor Cells from Radiation-Induced Cell Death [PDF]

open access: goldFrontiers in Oncology, 2018
Irradiation generates oxidized phospholipids that activate platelet-activating factor receptor (PAFR) associated with pro-tumorigenic effects. Here, we investigated the involvement of PAFR in tumor cell survival after irradiation. Cervical cancer samples
Ildefonso Alves da Silva-Junior   +4 more
doaj   +5 more sources

Systemic Chemotherapy Is Modulated by Platelet-Activating Factor-Receptor Agonists [PDF]

open access: yesMediators of Inflammation, 2015
Chemotherapy is used to treat numerous cancers including melanoma. However, its effectiveness in clinical settings is often hampered by various mechanisms.
Ravi P. Sahu   +2 more
doaj   +6 more sources

Biased signaling due to oligomerization of the G protein-coupled platelet-activating factor receptor [PDF]

open access: yesNature Communications, 2022
The functional consequence of G protein-coupled receptor oligomerization remains debated. Here the authors show that platelet-activating factor receptor oligomerization enhances G protein coupling, and restrains β-arrestin recruitment and internalization.
Junke Liu   +11 more
doaj   +3 more sources

Nuclear localization of platelet-activating factor receptor controls retinal neovascularization. [PDF]

open access: yesCell Discov, 2016
AbstractPlatelet-activating factor (PAF) is a pleiotropic phospholipid with proinflammatory, procoagulant and angiogenic actions on the vasculature. We and others have reported the presence of PAF receptor (Ptafr) at intracellular sites such as the nucleus.
Bhosle VK   +12 more
europepmc   +6 more sources

A Possible Role for Platelet-Activating Factor Receptor in Amyotrophic Lateral Sclerosis Treatment [PDF]

open access: goldFrontiers in Neurology, 2018
Amyotrophic lateral sclerosis (ALS) is the third most prevalent neurodegenerative disease affecting upper and lower motor neurons. An important pathway that may lead to motor neuron degeneration is neuroinflammation.
Marcelo R. S. Briones   +6 more
doaj   +4 more sources

Dissecting Bacterial Cell Wall Entry and Signaling in Eukaryotic Cells: an Actin-Dependent Pathway Parallels Platelet-Activating Factor Receptor-Mediated Endocytosis [PDF]

open access: yesmBio, 2017
The Gram-positive bacterial cell wall (CW) peptidoglycan-teichoic acid complex is released into the host environment during bacterial metabolism or death.
Lip Nam Loh   +2 more
doaj   +3 more sources

Platelet-Activating Factor-Receptor and Tumor Immunity. [PDF]

open access: yesJSM Cell Dev Biol, 2014
First described in 1972 by Benveniste and colleagues, platelet-activating factor (PAF) remains one of the potent phospholipid known to date. The role of PAF produced enzymatically in mediating diverse biological and pathophysiological processes including inflammatory and allergic diseases and cancers in response to various stimuli has been extensively ...
Sahu RP, Konger RL, Travers JB.
europepmc   +5 more sources

TNFα promotes mucosal wound repair through enhanced platelet activating factor receptor signaling in the epithelium. [PDF]

open access: yesMucosal Immunol, 2019
Pathobiology of several chronic inflammatory disorders, including ulcerative colitis and Crohn’s disease is related to intermittent, spontaneous injury/ulceration of mucosal surfaces.
Birkl D   +12 more
europepmc   +2 more sources

Macrophage Derived Platelet Activating Factor Implicated in the Resolution Phase of Gouty Inflammation [PDF]

open access: yesInternational Journal of Inflammation, 2014
Human blood derived in vitro differentiated monocytes or macrophages are a population of cells which have been investigated over the years to determine the role these cells play in the resolution phase of gout.
Darshna Yagnik
doaj   +3 more sources

Home - About - Disclaimer - Privacy